Events

Vivet Therapeutics Presenting New Results During 2019 ESGCT Annual Congress in Barcelona
Vivet Therapeutics Presenting New Results During 2019 ESGCT Annual Congress in Barcelona
22nd October, 2019
Dr. Gloria González-Aseguinolaza, Vivet Therapeutics CSO & Head of the Gene Therapy Dept. at FIMA will chair the "Liver gene… READ MORE
VIVET PRESENTING DURING 2019 GENE THERAPY FOR RARE DISORDERS EUROPE CONFERENCE IN LONDON
VIVET PRESENTING DURING 2019 GENE THERAPY FOR RARE DISORDERS EUROPE CONFERENCE IN LONDON
16th October, 2019
Anne Douar, Chief Development Officer of Vivet Therapeutics, will give a presentation ("Manufacturing of a New Gene Therapy Product: Long… READ MORE
VIVET ATTENDING Chardan's 3rd Annual Genetic Medicines Conference
VIVET ATTENDING Chardan's 3rd Annual Genetic Medicines Conference
7th October, 2019
Jean-Philippe Combal, Vivet Therapeutics' CEO, will be hosting 1x1 meetings during Chardan 's 3rd Annual Genetic Medicines Conference, Oct 7-8,… READ MORE
VIVET PRESENTING AT 2019 CELL & GENE MEETING ON THE MESA
VIVET PRESENTING AT 2019 CELL & GENE MEETING ON THE MESA
3rd October, 2019
Vivet Therapeutics CEO, Jean-Philippe Combal, will be giving a corporate presentation during 2019 Cell & Gene Meeting on the Mesa in Carlsbad on… READ MORE
Vivet is attending the SSIEM 2019 Symposium in Rotterdam
Vivet is attending the SSIEM 2019 Symposium in Rotterdam
3rd September, 2019
Jean-Philippe Combal, Vivet Therapeutics' CEO, Bernard Benichou -CMO and Gloria Gonzalez - CSO,  will be attending the SSIEM 2019 Symposium… READ MORE
VIVET ATTENDING BIO 2019 IN PHILADELPHIA ON JUNE 3-6
VIVET ATTENDING BIO 2019 IN PHILADELPHIA ON JUNE 3-6
3rd June, 2019
Vivet's CEO, Jean-Philippe Combal and Thomas Daniel, BD Director, will be hosting 1x1 meetings during BIO 2019 in Philadelphia on June 3-6. READ MORE
Vivet Therapeutics Announces 2 Abstracts Accepted For Oral Presentation At 2019 ASGCT
Vivet Therapeutics Announces 2 Abstracts Accepted For Oral Presentation At 2019 ASGCT
30th April, 2019
Vivet Therapeutics Announces 2 Abstracts Accepted For Oral Presentation At 2019 American Society Of Gene And Cell Therapy Annual Meeting… READ MORE
Vivet presenting at ARM 2019 Cell & Gene Meeting on the Med in Barcelona
Vivet presenting at ARM 2019 Cell & Gene Meeting on the Med in Barcelona
23rd April, 2019
Vivet Therapeutics CEO, Jean-Philippe Combal, will be giving a corporate presentation during the Cell & Gene Meeting on the Med organized… READ MORE
VIVET PRESENTING LEAD PRODUCT, VTX-801, AND PFIC INDICATION VTX-803, AT 2019 INTERNATIONAL LIVER CONGRESS
VIVET PRESENTING LEAD PRODUCT, VTX-801, AND PFIC INDICATION VTX-803, AT 2019 INTERNATIONAL LIVER CONGRESS
10th April, 2019
Vivet Therapeutics will be making a presentation on its lead product, VTX-801, at the upcoming 2019 International Liver Congress, April… READ MORE
VIVET ATTENDING 3RD ANNUAL GENE THERAPY FOR RARE DISORDERS CONFERENCE IN BOSTON
VIVET ATTENDING 3RD ANNUAL GENE THERAPY FOR RARE DISORDERS CONFERENCE IN BOSTON
26th March, 2019
Jean-Philippe Combal, Vivet Therapeutics' CEO, will be attending the 3rd Annual Gene Therapy for Rare Disorders conference in Boston (March 26-28 2019). READ MORE
Vivet presenting during the 2019 Bioprocessing Summit Europe in Lisbon
Vivet presenting during the 2019 Bioprocessing Summit Europe in Lisbon
19th March, 2019
Vivet Therapeutics' CEO, Jean-Philippe Combal, will be attending the 2019 Bioprocessing Summit Europe in Lisbon (March 19-21). He will give a presentation… READ MORE
Vivet attending DIA  Europe 2019 in Vienna on February 5-7
Vivet attending DIA Europe 2019 in Vienna on February 5-7
5th February, 2019
Anne Douar, Chief Development Officer of Vivet Therapeutics, will be attending the DIA Europe 2019 conference in Vienna on February 5-7. READ MORE
VIVET WILL BE AT THE 37TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
VIVET WILL BE AT THE 37TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
7th January, 2019
Jean-Philippe Combal, Vivet Therapeutics' CEO, Dr. Gloria Gonzalez, its CSO and Thomas Daniel, BD Director will be at the 37th Annual J.P.… READ MORE
Vivet presenting at 2018 Evercore ISI HEALTHCONx in Boston
Vivet presenting at 2018 Evercore ISI HEALTHCONx in Boston
27th November, 2018
Vivet Therapeutics CEO, Jean-Philippe Combal, will be giving a corporate presentation during 2018 Evercore ISI HealthCONx in Boston on November 27th. Jean-Philippe… READ MORE
VIVET ATTENDING JEFFERIES 2018 LONDON HEALTHCARE CONFERENCE
VIVET ATTENDING JEFFERIES 2018 LONDON HEALTHCARE CONFERENCE
14th November, 2018
Jean-Philippe Combal, Vivet Therapeutics' CEO, and Thomas Daniel, BD Director, will be hosting 1x1 meetings during Jefferies 2018 London Healthcare Conference on… READ MORE
VIVET PRESENTING DURING  2018 GENE THERAPY FOR RARE DISORDERS EUROPE CONFERENCE IN LONDON
VIVET PRESENTING DURING 2018 GENE THERAPY FOR RARE DISORDERS EUROPE CONFERENCE IN LONDON
24th October, 2018
Anne Douar, Chief Development Officer of Vivet Therapeutics, will give a presentation ("Finding the Right Dose From Mice to Human:… READ MORE
VIVET THERAPEUTICS ATTENDING 2018 ESGCT 26TH ANNUAL CONGRESS IN LAUSANNE
VIVET THERAPEUTICS ATTENDING 2018 ESGCT 26TH ANNUAL CONGRESS IN LAUSANNE
16th October, 2018
Vivet Therapeutics will be at the upcoming European Society of Gene And Cell Therapy (ESGCT) 26th annual congress in Lausanne… READ MORE
Vivet Presenting at 2018 Chardan Gene Therapy conference in New York
Vivet Presenting at 2018 Chardan Gene Therapy conference in New York
9th October, 2018
Vivet Therapeutics CEO, Jean-Philippe Combal, will be presenting and hosting 1x1 meetings during Chardan Gene Therapy conference in New York on October… READ MORE
Vivet attending FierceBiotech 3rd Drug Development Forum in Boston
Vivet attending FierceBiotech 3rd Drug Development Forum in Boston
1st October, 2018
Vivet Therapeutics' CEO, Jean-Philippe Combal, will be attending FierceBiotech 3rd Drug Development Forum in Boston (October 1-3 2018). He will be… READ MORE
VIVET ANNOUNCES PRESENTATIONS ON ITS LEAD PRODUCT VTX-801 AT THE 2018 COPPER MEETING
VIVET ANNOUNCES PRESENTATIONS ON ITS LEAD PRODUCT VTX-801 AT THE 2018 COPPER MEETING
24th September, 2018
Vivet Therapeutics announces different presentations on its lead product, VTX-801, at the upcoming 2018 Copper Meeting in Sorrento (Italy) on… READ MORE
VIVET ATTENDING WEDBUSH PACGROW 2018 HEALTHCARE CONFERENCE IN NEW YORK
VIVET ATTENDING WEDBUSH PACGROW 2018 HEALTHCARE CONFERENCE IN NEW YORK
15th August, 2018
Vivet Therapeutics' CEO, Jean-Philippe Combal will be giving a Corporate presentation (August 15 / 9.10-9.40am) and hosting 1x1 meetings during 2018… READ MORE
Vivet attending BIO 2018 in Boston on June 4-7
Vivet attending BIO 2018 in Boston on June 4-7
4th June, 2018
 Vivet's CEO, Jean-Philippe Combal and Thomas Daniel, BD Director, will be hosting 1x1 meetings during BIO 2018 in Boston on June 4-7. READ MORE
VIVET ANNOUNCES 2 PRESENTATIONS ON ITS LEAD PRODUCT VTX-801 AT THE 2018 ASGCT ANNUAL MEETING
VIVET ANNOUNCES 2 PRESENTATIONS ON ITS LEAD PRODUCT VTX-801 AT THE 2018 ASGCT ANNUAL MEETING
16th May, 2018
Vivet Therapeutics announces 2 presentations on its lead product, VTX-801, at the upcoming American Society of Gene and Cell Therapy… READ MORE
Vivet sponsoring and attending Wilson Disease Association (WDA) 2018 Annual Conference
Vivet sponsoring and attending Wilson Disease Association (WDA) 2018 Annual Conference
27th April, 2018
Vivet Therapeutics' CEO, Jean-Philippe Combal, and Bernard Benichou, Vivet's Chief Medical Officer will be attending the upcoming Wilson Disease Association… READ MORE
Vivet announces presentation on its lead product at the upcoming 2018 International Liver Congress
Vivet announces presentation on its lead product at the upcoming 2018 International Liver Congress
14th April, 2018
Vivet Therapeutics announces presentation on its lead product at the upcoming 2018 International Liver Congress, Paris April 14, 2018. Dr.… READ MORE
Vivet is sponsoring and attending the 9th Congress of the Spanish Society for Gene and Cell Therapy
Vivet is sponsoring and attending the 9th Congress of the Spanish Society for Gene and Cell Therapy
14th March, 2018
Vivet is a gold sponsor of the 9th Biennial Congress of the Spanish Society for Gene and Cell Therapy to… READ MORE
Vivet participating to a panel at 2018 Biotech & Money congress
Vivet participating to a panel at 2018 Biotech & Money congress
5th February, 2018
Jean-Philippe Combal, Vivet Therapeutics' CEO, will be part of a panel (Anatomy of a Private Finance Raise - Feb. 6… READ MORE
Vivet hosting meetings during JPM 2018 Healthcare Conference
Vivet hosting meetings during JPM 2018 Healthcare Conference
15th January, 2018
Jean-Philippe Combal, Vivet Therapeutics' CEO, Dr. Gloria Gonzalez, its CSO and Thomas Daniel, BD Director, will be hosting meetings during… READ MORE
Vivet attending Jefferies 2017 London Healthcare Conference
Vivet attending Jefferies 2017 London Healthcare Conference
15th November, 2017
Jean-Philippe Combal, Vivet Therapeutics' CEO, and Thomas Daniel, BD Director, will be hosting 1x1 meetings during Jefferies 2017 London Healthcare Conference on… READ MORE
Vivet will be at BIO Europe in Berlin on November 6-8th
Vivet will be at BIO Europe in Berlin on November 6-8th
6th November, 2017
Vivet Therapeutics will be at BIO Europe in Berlin on November 6-8th 2017 READ MORE
Vivet presenting at Gene Therapy for Rare Disorders Europe
Vivet presenting at Gene Therapy for Rare Disorders Europe
31st October, 2017
Vivet Therapeutics will be presenting at Gene Therapy for Rare Disorders Europe on Oct 31-Nov 2, 2017 READ MORE
Vivet will be at AASLD Liver Meeting 2017
Vivet will be at AASLD Liver Meeting 2017
20th October, 2017
Vivet Therapeutics will be at AASLD Liver Meeting 2017 in Washington on October 20-24th. READ MORE
Vivet at Mkt Access for Cell & Gene Therapies Congress in London
Vivet at Mkt Access for Cell & Gene Therapies Congress in London
18th October, 2017
Vivet Therapeutics will be attending the upcoming Market Access for Cell & Gene Therapies Conference held in London on Oct. 18-19,… READ MORE
Vivet at 25th anniversary ESGCT meeting in Berlin
Vivet at 25th anniversary ESGCT meeting in Berlin
17th October, 2017
Vivet Therapeutics will be at the upcoming European Society of Gene And Cell Therapy (ESGCT) annual meeting in Berlin on Oct. 17-20,… READ MORE
Show Archived
Vivet participates to market Access for Cell & Gene Therapies meeting
Vivet participates to market Access for Cell & Gene Therapies meeting
31st August, 2017
Vivet Therapeutics will participate to Market Access for Cell & Gene Therapies conference in London Oct. 18-19 READ MORE
Vivet will present at Cell & Gene meeting on the Mesa
Vivet will present at Cell & Gene meeting on the Mesa
30th August, 2017
Vivet Therapeutics announces presentation at the upcoming Cell & Gene meeting on the Mesa in La Jolla on Oct. 4-6,… READ MORE
Vivet presenting at Chardan Gene Therapy conference
Vivet presenting at Chardan Gene Therapy conference
30th August, 2017
Vivet Therapeutics announces presentation at the upcoming Chardan Inauguration Gene Therapy Conference in New York on October 10th. READ MORE